Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
作者信息
Honoré Stéphane, Gautret Philippe
机构信息
Service de Pharmacie, Hôpital Timone, AP-HM, Marseille, France; Laboratoire de Pharmacie Clinique, Aix Marseille Université, Marseille, France.
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ., IRD, AP-HM, SSA, VITROME, Marseille, France.
出版信息
Travel Med Infect Dis. 2021 Mar-Apr;40:101984. doi: 10.1016/j.tmaid.2021.101984. Epub 2021 Feb 5.
Abstract
摘要
相似文献
1
Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.回复阿利扎加（Alizazgar）J. 关于在新冠病毒肺炎患者中联合使用羟氯喹和阿奇霉素的风险
Travel Med Infect Dis. 2021 Mar-Apr;40:101984. doi: 10.1016/j.tmaid.2021.101984. Epub 2021 Feb 5.
2
Hydroxychloroquine + azithromycin treatment in elderly patients.老年患者的羟氯喹啉 + 阿奇霉素治疗
Int J Antimicrob Agents. 2021 Apr;57(4):106313. doi: 10.1016/j.ijantimicag.2021.106313. Epub 2021 Mar 11.
3
Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.新型冠状病毒肺炎患者使用羟氯喹和阿奇霉素治疗期间自我心电图监测的有效性和安全性
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):108-111. doi: 10.1016/j.rec.2020.08.020. Epub 2020 Oct 1.
4
Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.新冠病毒肺炎患者使用羟氯喹啉和阿奇霉素联合用药的风险
Travel Med Infect Dis. 2020 Nov-Dec;38:101881. doi: 10.1016/j.tmaid.2020.101881. Epub 2020 Sep 18.
5
Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19.接受羟氯喹啉-阿奇霉素联合治疗的COVID-19患者的心室复极指标
Bratisl Lek Listy. 2020;121(11):817-821. doi: 10.4149/BLL_2020_134.
6
Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.羟氯喹和阿奇霉素治疗新型冠状病毒肺炎（COVID-19）时QT间期延长的研究
J Coll Physicians Surg Pak. 2020 Oct;30(10):153-157. doi: 10.29271/jcpsp.2020.supp2.S153.
7
The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel Coronavirus disease 2019.羟氯喹和阿奇霉素对新型冠状病毒病患者校正 QT 间期的影响。
Rev Assoc Med Bras (1992). 2021 Jul;67(7):979-984. doi: 10.1590/1806-9282.20210380.
8
Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.从心脏角度看，与单独使用羟氯喹相比，羟氯喹与阿奇霉素联合用于治疗新冠病毒病是否是一个好的组合？一项系统评价和荟萃分析。
J Nepal Health Res Counc. 2021 Apr 23;19(1):1-9. doi: 10.33314/jnhrc.v19i1.3270.
9
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.新冠疫情中使用或不使用阿奇霉素的羟氯喹。回复。
N Engl J Med. 2021 Jan 14;384(2):191. doi: 10.1056/NEJMc2031780. Epub 2020 Dec 2.
10
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.羟氯喹/阿奇霉素治疗与 COVID-19 住院患者的 QT 间期延长。
JACC Clin Electrophysiol. 2021 Jan;7(1):16-25. doi: 10.1016/j.jacep.2020.07.016. Epub 2020 Aug 5.
本文引用的文献
1
Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.新冠病毒肺炎患者使用羟氯喹啉和阿奇霉素联合用药的风险
Travel Med Infect Dis. 2020 Nov-Dec;38:101881. doi: 10.1016/j.tmaid.2020.101881. Epub 2020 Sep 18.
2
Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes.阿奇霉素可延长QT间期并抑制心室收缩，但不会诱发尖端扭转型室性心动过速。
Cardiovasc Toxicol. 2015 Jul;15(3):232-40. doi: 10.1007/s12012-014-9289-4.
3
4
No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.抗生素莫西沙星或阿奇霉素在患有慢性房室传导阻滞的麻醉犬中无促心律失常特性。
Br J Pharmacol. 2006 Dec;149(8):1039-48. doi: 10.1038/sj.bjp.0706900. Epub 2006 Nov 6.
5
Is azithromycin treatment associated with prolongation of the Q-Tc interval?阿奇霉素治疗是否与Q-Tc间期延长有关？
Wien Klin Wochenschr. 2002 Jun 14;114(10-11):396-9.
Zotero 插件